VIDEOTAPE TO ENHANCE HIV COUNSELING & TESTING FOR WOMEN

艾滋病毒咨询和检测（“HIV C&T”）一直是美国艾滋病预防和治疗的基石。 预防工作，但其在减少妇女风险方面的有效性 被限制。 第二阶段SBIR的目标是： 1.制定与艾滋病毒C&T结合使用的创新干预措施 减少异性性行为将艾滋病毒传染给妇女-具体而言， 接受艾滋病毒C&T治疗的妇女及其男性观看的录像带 合伙人;以及 2.严格评估录像带在减少 无保护性交和增加伴侣检测。 该视频是第一阶段研究的产物。它旨在提高艾滋病毒 预防：（1）提高妇女对艾滋病毒基本知识的认识 咨询信息;（2）扩大咨询的范围，以妇女的 性伴侣，以及（3）帮助夫妇沟通艾滋病毒风险， 预防 干预措施将在一个 随机试验SBIR的最终产品将是一种创新的， 彻底接地，严格评估，成本效益和商业 可行的录像干预措施，以减少艾滋病毒的异性传播， 妇女 拟议的商业应用： 建议的视频将是非常有用的艾滋病毒咨询和检测 网站，包括性病诊所和医院，以及私人医生， 以及艾滋病教育和外展计划。彻底搜索相关的 数据库显示当前没有视频可用于HIV C&T;因此， 该产品的商业潜力很大。Miller-Fenwich，Inc. 市场计划旨在帮助医疗保健专业人员， 有效地将健康信息传达给患者， 对这个项目感兴趣，并认为它非常可行， 营销观点。

HIV counseling and testing ("HIV C&T") has been a cornerstone of U.S. prevention efforts, yet its effectiveness in reducing risk for women has been limited. The aims of this Phase II SBIR are: 1. To produce an innovate intervention for use in conjunction with HIV C&T to reduce heterosexual transmission of HIV to women-specifically, a videotape to be viewed by women who receive HIV C&T and their male partners; and 2. To rigorously evaluate the effectiveness of the videotape in reducing unprotected intercourse and increasing partner testing. The video is the product of Phase I research. It seeks to enhance HIV prevention by: (1) improving women's understanding of essential HIV counseling messages; (2) expanding the reach of counseling to the women's sexual partners, and (3) helping couple communicate about HIV risk and prevention. The intervention will undergo rigorous experimental evaluation in a randomized trial. The end product of this SBIR will be an innovative, thoroughly grounded, rigorously evaluated, cost-effective and commercially viable video intervention to reduce heterosexual transmission of HIV to women. Proposed commercial applications: The proposed video will be extremely useful to HIV counseling and Testing sites, including STD clinics and hospitals, as well as private physicians, and AIDS education and outreach programs. A thorough search of relevant databases shows no videos currently available for use with HIV C&T; thus, the commercial potential of this product is strong. Miller-Fenwich, Inc., markets programs designed to assist health care professionals in effectively communicating health information to patients, is very interested in this project and considers it extremely viable from a marketing standpoint.